Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

NCT03202303 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT03202303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03202303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Lead sponsor
Montefiore Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
April 12, 2019
Completion date
February 28, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder